The Society encourages and supports research in gastroenterology and hepatology in New Zealand. This includes research into the causes, diagnosis and treatment of conditions affecting the gastrointestinal tract and liver. Research activities fall into 3 main types: Basic Science (laboratory-based), Clinical Research (involving patients and doctors), and Clinical Trials (usually new drug treatments).

New Zealand IBD Clinical Trials Network

The listed units have established facilities for conducting clinical trials in inflammatory bowel disease and are currently participating in trials of new treatments in New Zealand.  It is possible that other units will join this network also. 

Department of Gastroenterology and Hepatology
Auckland Hospital
Investigator: Dr David Rowbotham Clinical Trial Coordinators Dee Yang
Tel: +64 9 3074949 ext 25581 Fax: +64 9 3078984

Department of Gastroenterology
Wellington Hospital
Investigator:  Dr Ben Griffiths & Dr Rees Cameron
Research Nurse: Jonathan Barrett
Tel: 04 9185136

Department of Gastroenterology
Waikato Hospital
Investigator:  Dr Frank Weilert
Clinical Trial Coordinators / Research Nurses: Chris Tuffery, Nancy Sullivan, Sherryl Hayett
Tel: +64 7 839 8899 ext 23017 Fax: +64 7 858 0984

Department of Gastroenterology
Hawke's Bay Hospital
Investigator:  Dr Malcolm Arnold
Research Coordinator: Diana Schmid
Tel: +64 6 8788109 ext 6628 Fax: +64 6 8781328


North Shore Hospital
North Shore, Auckland
Investigator:  Dr Nathan Atkinson & Dr Ratna Pandey
Study Coordinator: Sonia Bindon

Tel: +64 9 486 8920 x 3309 or 027 2752578

Department of Gastroenterology
Christchurch Hospital
Investigator: Prof Richard Gearry
Trial Manager: Katherine Denton 
Coordinators/Research Nurses: Rhondda Brown and Tracy Noonan
Tel: +64 3 3640135 Fax: +64 3 3641624

Department of Gastroenterology and Hepatology 
Middlemore Hospital
Investigator: Dr Tien Huey Lim
Tel: +64 9 2760044  ext 8749  

Department of Gastroenterology
Dunedin Public Hospital
Investigator:  Dr Michael Schultz
Research Nurse: Aroha Bolton and Dawn France
Tel: +64 3 474 0009 ext. 58054 Fax: +64 3 470 9358

Advantages of conducting clinical trials in New Zealand include:

  • A single national ethics committee process with no cost attached. The committee meets monthly.
  • A rapid regulatory approval process via the SCOTT committee, which acts under the auspices of the HRC. SCOTT committee turnaround time is usually less than 4 weeks.
  • There are large numbers of patients with IBD in New Zealand, which has one of the highest incidence rates in the world.
  • New Zealand has limited access to new biological therapies in normal clinical practice.